Related Experiment Video
Updated: Aug 16, 2026

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension
Published on: May 17, 2024
Hypertension in the elderly
Michael Maddens1, Khaled Imam, Ayham Ashkar
1Division of Geriatric Medicine, William Beaumont Hospital, 3535 West 13 Mile Road, Suite 108, Royal Oak, MI 48073, USA. mmaddens@beaumont.edu
Insights
Treating hypertension in elderly patients can reduce adverse cardiovascular events, but benefits in the very elderly are unclear, with potential risks to overall mortality. Careful blood pressure targets are crucial to avoid negative cognitive effects.
Area of Science:
- Gerontology
- Cardiovascular Medicine
- Clinical Pharmacology
Background:
- Hypertension is a significant risk factor for adverse events in elderly individuals.
- The benefits and risks of hypertension treatment in the very elderly (over 80) require careful consideration.
- Current guidelines for target blood pressures in older adults remain a subject of debate.
Purpose of the Study:
- To review the evidence regarding hypertension treatment in the elderly.
- To discuss the complexities of blood pressure targets and potential risks in very elderly patients.
- To evaluate the role of lifestyle modifications and pharmacological interventions.
Main Methods:
- Literature review of studies on hypertension management in elderly populations.
- Analysis of data concerning cardiovascular outcomes, overall mortality, and cognitive function.
- Evaluation of treatment strategies including lifestyle changes and pharmacotherapy.
Main Results:
- Hypertension treatment reduces cardiovascular events in the elderly up to age 80.
- In the very elderly, treatment may decrease cardiovascular events but potentially increase overall mortality.
- Lowering systolic blood pressure (SBP) below 159 mm Hg is beneficial, but caution is advised if diastolic blood pressure (DBP) falls below 65 mm Hg or the day-night BP difference exceeds 20%.
- Aggressive SBP reduction below 135 mm Hg may accelerate cognitive decline.
Conclusions:
- While hypertension treatment offers benefits for cardiovascular outcomes in the elderly, the impact on overall mortality in the very elderly is less clear.
- Individualized blood pressure targets are essential, considering potential risks like cognitive decline and increased mortality.
- Lifestyle modifications (sodium restriction, exercise, weight loss) and judicious use of first-line agents like thiazides are recommended, with careful monitoring for side effects.
Abstract:
Hypertension is predictive of a wide variety of subsequent adverse events in elderly patients, at least up to the age of 80 years. Treatment can reduce these adverse outcomes, although the benefits in the very elderly remain somewhat unclear. In the very elderly, there appears to be a reduction in cardiovascular events, but this reduction is perhaps at the expense of an increase in overall mortality. Target BPs in the elderly remain controversial. Among patients who have not had previous stroke or significant cardiovascular or renal disease, the benefits of reducing the SBP below 159 mm Hg are well documented. There is some evidence to suggest, however, that if doing so increases the day-night difference in BP by more than 20% or is associated with a decline in DBP below 65 mm Hg, then the benefits of treatment may be attenuated or lost. In addition, there is some suggestion that reducing SBP consistently below 135 mm Hg may accelerate cognitive decline. There appears to be a role for sodium restriction in those who can comply without otherwise compromising nutrient intake. Likewise, exercise may be beneficial and have benefits beyond simply lowering BP. Weight loss in those who are overweight may also help in lowering the BP. For most patients, low-dose thiazides such as hydrochlorothiazide are likely to be the appropriate first-line therapy (even in patients who have diabetes) unless they exacerbate or precipitate urinary incontinence or gout or complicate concomitant drug therapy (eg, lithium treatment of bipolar disorder). In very elderly patients, the apparent beneficial effects on strokes, major cardiovascular events, and heart failure rates may justify treating despite lack of benefit on overall mortality.
Related Concept Videos
Drug Dosing: Geriatric Patients
Hypertension I: Introduction
Hypertension and Regulation of Blood Pressure
Hypertension III: Clinical Manifestations and Diagnostic Studies
Pharmacodynamics in Geriatric Patients: Effects of Age
Hypertension V: Nursing Management